AstraZeneca PLC Files 6-K on Director Shareholdings
Ticker: AZN · Form: 6-K · Filed: May 23, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, shareholding, disclosure
Related Tickers: AZN
TL;DR
AZN filed a 6-K showing director/PDMR shareholdings.
AI Summary
AstraZeneca PLC filed a Form 6-K on May 23, 2025, reporting director and PDMR shareholdings. The filing indicates AstraZeneca is a foreign issuer submitting its annual report under Form 20-F.
Why It Matters
This filing provides transparency into the holdings of key individuals within AstraZeneca, which can be an indicator of insider confidence.
Risk Assessment
Risk Level: low — This is a routine disclosure of shareholdings by directors and PDMRs, not indicating any new material events.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the Form 6-K
- 001-11960 (company) — SEC File Number for AstraZeneca PLC
- 20250523 (date) — Filing date of the Form 6-K
FAQ
What type of report is this Form 6-K?
This Form 6-K is a Report of Foreign Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Who is the filer of this report?
The filer is AstraZeneca PLC.
What is the filing date of this report?
The filing date is May 23, 2025.
Does AstraZeneca PLC file annual reports under Form 20-F or 40-F?
AstraZeneca PLC indicates it files annual reports under cover of Form 20-F.
What is the primary subject of this Form 6-K filing?
This Form 6-K filing pertains to Director/PDMR Shareholding.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 23, 2025 regarding ASTRAZENECA PLC (AZN).